Public Advisory - Generic acetaminophen by Teva recalled because it may contain foreign material

OTTAWA, ON, Sept. 10, 2026 /CNW/ -- 

Summary
Product: Novo-Gesic Forte 500 mg tablets (acetaminophen)
Issue: Health product - Contamination; Health product - Product quality
What to do: Immediately stop using the affected product. Return it to the pharmacy where it was purchased for a replacement and for proper disposal.

Novo-Gesic Forte 500 mg - front

Novo-Gesic Forte 500 mg - back

Novo-Gesic Forte 500 mg - caplet

Affected products

Product	DIN	Lot	Expiry
Novo-Gesic Forte 500 mg (acetaminophen)	00482323	100083040	January 31, 2029

Issue

Teva Canada Limited is recalling one lot of the non-prescription drug Novo-Gesic Forte 500 mg (acetaminophen) due to the potential presence of phenolic resin or epoxy which, if ingested, may cause injury to the digestive system. The affected product was supplied to pharmacies in 1,000-count bottles and was dispensed to patients in smaller quantities.

Health Canada is monitoring the recall and the company's preventative and corrective actions. If additional safety concerns arise, Health Canada will take appropriate action and inform Canadians as needed.

What you should do

• Immediately stop using the affected product and return it to your local pharmacy for replacement and proper disposal. If you are unsure whether your product is recalled, check with your pharmacy.
• Consult your healthcare practitioner if you have used the affected product and have concerns about your health.
• Contact Teva Canada Customer Care by calling toll-free at 1-800-268-4129 or by email at [email protected], if you have questions about this recall.
• Report any health product-related side effects or complaints to Health Canada.

Alert / recall type: Public Advisory
Category: Drug
Companies: 
Teva Canada Limited
Medical Affairs & Drug Information
30 Novopharm Court
Toronto, Ontario M1B 2K9
[email protected]
Published by: Health Canada
Distribution: National
Recall class: Type I
Depth of recall: Consumers

SOURCE Health Canada (HC)

Media Enquiries: Health Canada, 613-957-2983, [email protected]; Public Enquiries, 613-957-2991, 1-866 225-0709, [email protected]